Talisman Energy (TSX: TLM) is expected to report Q2 earnings on July 31. Here's what Wall Street wants to see:
The 10-second takeaway
Comparing the upcoming quarter to the prior-year quarter, average analyst estimates predict Talisman Energy's revenues will decrease -27.2% and EPS will wane -71.4%.
The average estimate for revenue is $1.34 billion. On the bottom line, the average EPS estimate is $0.02.
Last quarter, Talisman Energy reported revenue of $1.11 billion. GAAP reported sales were 44% lower than the prior-year quarter's $2.00 billion.
Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.
Last quarter, non-GAAP EPS came in at -$0.06. GAAP EPS were -$0.21 for Q1 versus $0.24 per share for the prior-year quarter.
Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.
For the preceding quarter, gross margin was 66.2%, 270 basis points worse than the prior-year quarter. Operating margin was 0.8%, much better than the prior-year quarter. Net margin was -18.9%, much worse than the prior-year quarter.
The full year's average estimate for revenue is $5.85 billion. The average EPS estimate is $0.14.
The stock has a three-star rating (out of five) at Motley Fool CAPS, with 547 members out of 572 rating the stock outperform, and 25 members rating it underperform. Among 100 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 92 give Talisman Energy a green thumbs-up, and eight give it a red thumbs-down.
Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Talisman Energy is hold, with an average price target of $13.40.
Is Talisman Energy the right energy stock for you? Read about a handful of timely, profit-producing plays on expensive crude in "3 Stocks for $100 Oil." Click here for instant access to this free report.
- Add Talisman Energy to My Watchlist.
Seth Jayson had no position in any company mentioned here at the time of publication. You can view his stock holdings here. He is co-advisor of Motley Fool Hidden Gems, which provides new small-cap ideas every month, backed by a real-money portfolio. The Motley Fool has no position in any of the stocks mentioned. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.
More from The Motley Fool
What's Juno Therapeutics Worth to Celgene?
Celgene may be considering a multibillion-dollar bid to acquire Juno.
Why Ascena Retail Group Inc. Stock Plunged 62% in 2017
The parent company of maurices just finished a tough year. Here's what investors need to know.
3 Easy Ways to Invest in India for 2018
Here's how to get access to this exciting emerging market.